ACTINIC KERATOSIS MARKET ANALYSIS

Actinic Keratosis Market, By Treatment Type (Topical Treatment, Surgical Procedure, Photodynamic Therapy, and Others), By End User (Hospitals, Dermatology Clinics, Spas and Rejuvenation Centers, Homecare Settings, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024
Code : CMI1006
Pages :175
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Actinic Keratosis Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Research and Development Activities by Key Market Players

Increasing research and development activities by key market players are expected to drive the global actinic keratosis market during the forecast period. For instance, in January 2023, Bioforntera AG, a biopharmaceutical company, announced that it had initiated Phase 3 clinical trial to evaluate the safety and efficacy of Ameluz in a field-directed treatment of actinic keratosis (AK) on the extremities, neck, and trunk.

Key Players Insights